Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Patent
1996-07-30
1999-11-30
Mosher, Mary E.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
4241991, 435 691, 435 693, 4352351, 435440, 536 2372, 935 65, A61K 3912, C12N 700, C12N 701
Patent
active
059938218
ABSTRACT:
The invention, in one aspect, is directed to a modified papilloma virus L2 protein which does not bind DNA or which has a substantially impaired ability to bind DNA compared to wild-type papilloma virus L2 protein. The invention is also directed to a method of producing one or more virus-like particles comprising a modified papilloma virus L2 protein according to the invention. The invention also resides in virus-like particles produced from this method.
Frazer Ian
Zhou Jian
CSL Limited
Mosher Mary E.
Salimi Ali R
The University of Queensland
LandOfFree
Modified papilloma virus L2 protein and VLPs formed therefrom does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modified papilloma virus L2 protein and VLPs formed therefrom, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified papilloma virus L2 protein and VLPs formed therefrom will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1668174